TY - JOUR
T1 - Variants in the 3′UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression
AU - Schmitt, Ina
AU - Wüllner, Ullrich
AU - Van Rooyen, Jan Pierre
AU - Khazneh, Hassan
AU - Becker, Julian
AU - Volk, Alexander
AU - Kubisch, Christian
AU - Becker, Tim
AU - Kostic, Vladimir S.
AU - Klein, Christine
AU - Ramirez, Alfredo
PY - 2012/12/1
Y1 - 2012/12/1
N2 - Alpha-synuclein (SNCA) is a major risk gene for Parkinson's disease (PD) and increased SNCA gene dosage results in a parkinsonian syndrome in affected families. Regulatory regions relevant for SNCA expression include the 3′ untranslated region (UTR), which among other regulatory elements contains several micro-RNA-binding sites. Interestingly, variants located in the 3′ region of SNCA have been associated with PD in two genome-wide association studies. To test whether private mutations in this region contribute to PD, we sequenced the 3′UTR of SNCA in 1285 PD patients and 1120 age/sex-matched healthy controls. We found two rare variants, the one corresponding to the single nucleotide polymorphism rs145304567 and the novel variant c.*1004 1008delTTTTT. Although rs145304567 affects the putative-binding site of microRNA (miRNA)-433, the allele distribution was similar in PD patients and controls, and the expression of SNCA mRNA was not related to the genotype. Furthermore, a regulatory effect of miRNA-433 on SNCA expression levels was not detected.
AB - Alpha-synuclein (SNCA) is a major risk gene for Parkinson's disease (PD) and increased SNCA gene dosage results in a parkinsonian syndrome in affected families. Regulatory regions relevant for SNCA expression include the 3′ untranslated region (UTR), which among other regulatory elements contains several micro-RNA-binding sites. Interestingly, variants located in the 3′ region of SNCA have been associated with PD in two genome-wide association studies. To test whether private mutations in this region contribute to PD, we sequenced the 3′UTR of SNCA in 1285 PD patients and 1120 age/sex-matched healthy controls. We found two rare variants, the one corresponding to the single nucleotide polymorphism rs145304567 and the novel variant c.*1004 1008delTTTTT. Although rs145304567 affects the putative-binding site of microRNA (miRNA)-433, the allele distribution was similar in PD patients and controls, and the expression of SNCA mRNA was not related to the genotype. Furthermore, a regulatory effect of miRNA-433 on SNCA expression levels was not detected.
UR - http://www.scopus.com/inward/record.url?scp=84869228626&partnerID=8YFLogxK
U2 - 10.1038/ejhg.2012.84
DO - 10.1038/ejhg.2012.84
M3 - Journal articles
C2 - 22617348
AN - SCOPUS:84869228626
SN - 1018-4813
VL - 20
SP - 1265
EP - 1269
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 12
ER -